Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Papillomavirus Infections 9Uterine Cervical Neoplasms 4Neuroendocrine Tumors 4Autoimmune Diseases 3Prostatic Neoplasms 2Neoplasms 2Abortion, Spontaneous 2Recurrence 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neuroblastoma 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Emapalumab 2Data Collection 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Lymphohistiocytosis, Hemophagocytic × Data Collection × Clear all
NCT03259230 2024-09-19

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Swedish Orphan Biovitrum

Completed
40 enrolled 43 charts
Myeloid

Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡